title: Ustekinumab in the treatment of refractory chronic cutaneous lupus erythematosus: a case report.
authors.forename: Christine
authors.initials: C
authors.lastname: Dahl
authors.forename: Claus
authors.initials: C
authors.lastname: Johansen
authors.forename: Knud
authors.initials: K
authors.lastname: Kragballe
authors.forename: Anne Braae
authors.initials: AB
authors.lastname: Olesen
mesh_terms: D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001706:Biopsy; D002908:Chronic Disease; D004351:Drug Resistance; D005260:Female; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D012074:Remission Induction; D012720:Severity of Illness Index; D012867:Skin / Q000187:drug effects* / Q000276:immunology / Q000473:pathology; D013997:Time Factors; D016896:Treatment Outcome; D000069549:Ustekinumab
chemical_list: D000893:Anti-Inflammatory Agents; D061067:Antibodies, Monoclonal, Humanized; D000069549:Ustekinumab